Knowledge Center
Patent / Jun 29, 2017
Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
Source:
US 20170182071 A1 20170629
The invention relates to a topical suspension formulation that includes a tetracycline, a liq. medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liq. medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 μ.
Also in the Knowledge Center
/ Oct 08, 2015
Improved spray drying process for production of powders with enhanced properties
Read more
Scientific Article
Scientific Article
/ Dec 01, 2015
The importance of human factors in inhaler development: The making of PowdAir®
Read more
Scientific Article